Table 4.

List of metabolites that exhibited different concentrations in control and IRI serum samples

			Preserum		Postserum
Metabolite, ppm	P Value	Fold Changea	mM	SD	mM	SD
Alanine
1.50	2.78E−03	1.42	4.14E−01	4.60E−01	1.51E−01	1.35E−01
3.80	**b	**	**	**	**	**	ov
Citrate
2.56	8.45E−02	−1.15	2.92E−01	2.92E−01	3.68E−01	4.06E−01
2.68	1.24E−02	−1.90	1.92E−01	2.62E−01	−2.32E−01	3.67E−01
Creatinine
3.06	6.96E−04	−3.19	1.07E−01	5.98E−02	3.25E−01	2.20E−01
4.05	1.70E−02	−2.08	**	**	**	**	ov
Glucose
3.26	9.30E−01	−1.01	**	**	**	**	ov
3.43	7.82E−01	−1.03	4.43E+00	3.07E+00	3.62E+00	2.75E+00
3.51	2.04E−01	1.16	4.29E+00	3.59E+00	3.19E+00	2.34E+00
3.56	8.21E−01	1.02	**	**	**	**	ov
3.75	8.52E−01	1.02	**	**	**	**	ov
3.79	6.15E−01	−1.05	4.03E+00	3.59E+00	3.03E+00	2.75E+00
3.85	8.20E−01	−1.03	**	**	**	**	ov
3.93	6.82E−01	−1.04	**	**	**	**	ov
4.67	5.13E−01	1.07	4.34E+00	2.46E+00	3.35E+00	2.46E+00
5.26	7.64E−01	1.03	4.04E+00	3.11E+00	3.65E+00	2.26E+00
Lactate
1.35	9.38E−02	1.13	6.29E+00	6.04E+00	3.40E+00	2.35E+00
4.11	**	**	**	**	**	**	ov
Phenylalanine
7.35	5.26E−05	−1.71	7.45E−02	9.58E−02	5.86E−02	2.84E−02
7.40	7.79E−03	−1.43	7.54E−02	9.51E−02	5.76E−02	2.72E−02
7.44	9.32E−01	1.03	7.38E−02	9.55E−02	5.58E−02	2.90E−02
4	**	**	**	**	**	**	ov
3.3	**	**	**	**	**	**	ov
3.1	**	**	**	**	**	**	ov
Tyrosine
6.91	2.17E−05	1.65	1.07E+00	1.77E+00	2.80E−01	2.62E−01
7.21	2.14E−03	1.35	1.08E+00	1.28E+00	2.88E−01	2.67E−01
3.90	**	**	**	**	**	**	ov
3.20	**	**	**	**	**	**	ov
3.00	**	**	**	**	**	**	ov
Valine
1.01	2.58E−05	1.44	3.51E−01	4.72E−01	1.05E−01	5.42E−02
1.06	6.01E−06	1.59	3.65E−01	4.67E−01	1.39E−01	5.70E−02
3.20	**	**	**	**	**	**	ov
3.60	**	**	**	**	**	**	ov

^aFold changes were calculated by control/IRI. Therefore, positive values indicate decreased concentration in IRI serum and negative values indicate increased concentration in IRI serum.

^bDouble asterisks indicate that the peaks were overlapped (ov), and a reliable P value or fold change could not be calculated.